https://www.selleckchem.com/pr....oducts/pkm2-inhibito
Carcinomatous changes were seen in 14 cases (17%) (high-grade dysplasia/carcinoma in situ in 7, intraductal papillary neoplasm 1, and invasive carcinoma 6); and 13/14 of these occurred in pathologic category I, all with cyst size 1 cm. In conclusion, diagnostic imaging guidelines used in Asia are not routinely used (but should be adopted) in the West. Pathologically, cases designated as CC are classifiable in 3 groups category 1 (dilated native duct type), more prone to carcinomatous change; category 2, double-duc
Like
Comment
Share
